SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-18-004279
Filing Date
2018-10-25
Accepted
2018-10-25 17:16:34
Documents
2
Period of Report
2018-10-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1714
2 SHERMAN POA sherman-16poa.txt EX-24 3507
  Complete submission text file 0001562180-18-004279.txt   6723
Mailing Address C/O ACCELERON PHARMA INC 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Sherman Matthew L (Reporting) CIK: 0001325710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 181139678

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research